Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
 wosene.asefa@nih.gov
240-276-6422 		5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
 kajal.biswas2@nih.gov
240-276-5614 		5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
 brian.cholewa@nih.gov
240-276-7545 		5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
 john.clifford@nih.gov
202-235-4482 		5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
 vignesh.gunasekharan@nih.gov
240-276-5814 		5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
 altaf.mohammed@nih.gov
240-276-6082 		5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
 ancy.nalli@nih.gov
202-276-5265 		5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
 shizuko.sei@nih.gov
240-276-5005 		5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
 robert.shoemaker@nih.gov
240-276-7077 		5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
 anda.vlad@nih.gov
240-276-6422 		5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name PI Organization Title Grant Number Program Official
Kibel, Adam S

Brigham And Women'S Hospital
United States

 Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer 5U01CA268810-03 Guillermo Marquez, Ph.D.
Kim, Hyung L

Cedars-Sinai Medical Center
United States

 Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer 5R01CA280060-03 Howard L. Parnes, M.D.
Kim, Michelle Kang

Cleveland Clinic Lerner Com-Cwru
United States

 Assessing feasibility of gastric cancer screening in the US 1R37CA300540-01 Claire Zhu, Ph.D.
Kirkwood, Kimberly Saunders

University Of California, San Francisco
United States

 Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer 5U01CA282269-02 Matthew Young, Ph.D.
Kisiel, John

Mayo Clinic Rochester
United States

 Multi-cancer Early Detection 2R01CA214679-08 Matthew Young, Ph.D.
Kleckner, Amber Simmons

University Of Maryland Baltimore
United States

 Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies 5R01CA284082-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Klein, Alison P

Johns Hopkins University
United States

 Improving Management of patients at High Risk of Pancreatic Cancer 1R01CA299421-01 Matthew Young, Ph.D.
Klopp, Ann

University Of Tx Md Anderson Can Ctr
United States

 Defining a globally accessible and pragmatic predictive signature (GAPPS) for locally advanced cervical cancer 1R01CA301124-01 Goli Samimi, Ph.D., M.P.H.
Knoerl, Robert James

University Of Michigan At Ann Arbor
United States

 Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors. 5R34CA286712-02 Goli Samimi, Ph.D., M.P.H.
Kober, Kord Michael

University Of California, San Francisco
United States

 An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach 5R37CA233774-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kolb, Noah Allan

University Of Vermont & St Agric College
United States

 Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy 5R01CA247517-05 Brennan Streck, Ph.D., RN, M.P.H.
Kong, Mei

University Of California-Irvine
United States

 Using dietary glutamine supplementation for melanoma prevention and targeted therapy 5R01CA244360-05 Gabriela Riscuta, M.D., CNS
Kooperberg, Charles L

Fred Hutchinson Cancer Center
United States

 Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) 5UG1CA287013-02 Elyse LeeVan, M.D., M.P.H.
Kresty, Laura A

University Of Michigan At Ann Arbor
United States

 Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma 1UG3CA299397-01 Altaf Mohammed, Ph.D.
Krist, Alexander H

Virginia Commonwealth University
United States

 Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) 3UG1CA287017-02S1 Elyse LeeVan, M.D., M.P.H.